163 related articles for article (PubMed ID: 21240839)
1. Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans.
Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Quetin-Leclercq J; Martin A
Planta Med; 2011 Apr; 77(6):641-6. PubMed ID: 21240839
[TBL] [Abstract][Full Text] [Related]
2. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
[TBL] [Abstract][Full Text] [Related]
4. Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective.
Tsouh PV; Addo P; Yeboah-Manu D; Boyom FF
J Pharmacol Toxicol Methods; 2015; 73():27-33. PubMed ID: 25792087
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease.
Tsouh Fokou PV; Kissi-Twum AA; Yeboah-Manu D; Appiah-Opong R; Addo P; Tchokouaha Yamthe LR; Ngoutane Mfopa A; Fekam Boyom F; Nyarko AK
Molecules; 2016 Apr; 21(4):445. PubMed ID: 27089314
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.
Portaels F; Traore H; De Ridder K; Meyers WM
Antimicrob Agents Chemother; 1998 Aug; 42(8):2070-3. PubMed ID: 9687409
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth.
Adusumilli S; Haydel SE
BMC Complement Altern Med; 2016 Jan; 16():40. PubMed ID: 26833071
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
[TBL] [Abstract][Full Text] [Related]
9. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.
Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T
Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268
[TBL] [Abstract][Full Text] [Related]
10. Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment.
Scherr N; Pluschke G; Thompson CJ; Ramón-García S
PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003996. PubMed ID: 26270480
[TBL] [Abstract][Full Text] [Related]
11. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
12. Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".
Watanabe T; Ohkusu K; Nakanaga K; Ishii N; Nakashima K; Shindo M; Yoshida Y; Yamamoto O
Eur J Dermatol; 2010; 20(6):809-10. PubMed ID: 20822972
[No Abstract] [Full Text] [Related]
13. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
[TBL] [Abstract][Full Text] [Related]
14. Beninese Medicinal Plants as a Source of Antimycobacterial Agents: Bioguided Fractionation and In Vitro Activity of Alkaloids Isolated from Holarrhena floribunda Used in Traditional Treatment of Buruli Ulcer.
Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Martin A; Quetin-Leclercq J
Biomed Res Int; 2015; 2015():835767. PubMed ID: 26180813
[TBL] [Abstract][Full Text] [Related]
15. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
Walsh DS; Portaels F; Meyers WM
Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of
Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y
Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683
[TBL] [Abstract][Full Text] [Related]
17. The Buruli Ulcer.
Kumar S; Basu S; Bhartiya SK; Shukla VK
Int J Low Extrem Wounds; 2015 Sep; 14(3):217-23. PubMed ID: 26286931
[TBL] [Abstract][Full Text] [Related]
18. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
Zhang T; Li SY; Converse PJ; Grosset JH; Nuermberger EL
PLoS Negl Trop Dis; 2013; 7(12):e2598. PubMed ID: 24367713
[TBL] [Abstract][Full Text] [Related]
19. [Buruli ulcer re-emergent infection].
Adou L
Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):125-33. PubMed ID: 20422927
[TBL] [Abstract][Full Text] [Related]
20. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-
Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]